Using Droplet Digital PCR to Quantify Early Rejection Biomarkers in Transplant Patients

Researchers at Chronix Biomedical applied Bio-Rad's ddPCR technology to quantify graft-derived cell-free DNA (cfDNA) in recent liver transplant patients and in stable patients who had undergone a transplant procedure more than six months earlier.